Intraoperative Ultrasound Guided Compared to Stereotactic Navigated Ventriculoperitoneal Shunt Placement

Hydrocephalus Clinical Trial

— NaVPS  

Official title:

Intraoperative Ultrasound Guided Compared to Stereotactic Navigated Ventriculoperitoneal Shunt Placement: A Randomized Controlled Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04450797
• Other study ID #: 2019-02157; ch20Leu
• Status: Recruiting
• Phase: N/A
• Start date: February 26, 2020
• Est. completion date: February 2025

Study information

• Verified date: May 2024
• Source: University Hospital, Basel, Switzerland
• Contact: Severina Leu, Dr. med.
• Phone: 0041 76 537 84 28
• Email: Severina.Leu[@]usb.ch
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study is to prospectively compare Ultrasound guided (US-G) Ventriculoperitoneal Shunt (VPS) placement to stereotactic navigation in a randomized controlled fashion with the surgical intervention time as primary outcome. All patients entering the University Hospital of Basel for elective or emergent VPS surgery will be randomized in 1:1 fashion to one of the study groups at admission or the day before the operation.

Description:

Ventriculoperitoneal shunt (VPS) placement is one of the most frequent procedures in neurosurgical practice. The position of the proximal ventricular catheter is important since it influences possible malfunction of the VPS. For the improvement of accuracy in proximal VPS placement, navigation-based insertion techniques have been developed. VPS placement using stereotactic navigation has shown a high accuracy of catheter placement been developed. VPS placement using stereotactic navigation has shown a high accuracy of catheter placement, while the main limitations are that for referencing, the head of the patient needs to be fixed in a head holder and the preoperative set-up can be time-consuming. US-G VPS placement using a burr hole probe was described as an alternate for image-guided VPS placement technique. For US-G VPS placement head fixation or preoperative registration is not needed. This study is to prospectively compare Ultrasound guided (US-G) Ventriculoperitoneal Shunt (VPS) placement to stereotactic navigation in a randomized controlled fashion with the surgical intervention time as primary outcome.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 136
• Est. completion date: February 2025
• Est. primary completion date: August 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Informed Consent as documented by signature

• Patients undergoing elective or emergent VPS placement (frontal or occipital shunt )

Exclusion Criteria:

• Revision surgery due to former VPS placement using the same side and location for VPS placement or when no complete shunt is revised (proximal and distal), resulting in a shorter operation time

• Ventriculoatrial or ventriculopleural Placement

• Women who are pregnant or breast feeding

• Intention to become pregnant during the course of the study

• Previous enrolment into the current study

• Enrolment of the investigator, his/her family members, employees, and other dependent persons

Related Conditions & MeSH terms

• Hydrocephalus
• Ventriculoperitoneal Shunt (VPS)

Intervention

Device:
• US -G VPS placement, done by BK Medical 5000 US with burr hole probe (type 9063 N11C5S, 11-5 MHz).
US -G VPS placement, done by BK Medical 5000 US with burr hole probe (type 9063 N11C5S, 11-5 MHz). Head not fixed, placed on horseshoe head holder, no preoperative navigation planning, catheter will be cut in length after positioning under real-time US guidance.
• Stereotactic navigation for VPS placement (Brainlab Dual Curve System with cranial navigation software version 3.1).
Stereotactic navigation for VPS placement (Brainlab Dual Curve System with cranial navigation software version 3.1). Head fixed in head clamp, entry point, trajectory and catheter length planned based on preoperative computer tomography imaging, catheter placed using navigated stylet.

Locations

Country	Name	City	State
Switzerland	Department of Neurosurgery, University Hospital of Basel	Basel

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Basel, Switzerland

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	surgical intervention time (minutes)	time spent in the Operating Room (OR) by the surgeon, includes preparation time together (patient positioning, head clamping in the stereotactic navigation group) with the operation time of the neurosurgical part. Beginning ("positioning") and ending ("suture neurosurgical part") of this time interval is clearly defined and will be in a standardized manner recorded by blinded anaesthesiologists. . In the stereotactic navigation group, an additional 5 minutes will be added to the surgical intervention time for the preplanning of the navigation the day before the operation on the Brainlab workstation.	at Operation day (V2, up to 24 hours)
Secondary	Operation time (minutes)	Operation time (minutes): time in minutes from "cut" to "suture"	at Operation day (V2, up to 24 hours)
Secondary	Anaesthesia time (minutes)	Anaesthesia time (minutes): time in minutes from "start anaesthesia" to "end anaesthesia"	at Operation day (V2, up to 24 hours)
Secondary	Number of puncture attempts	Number of puncture attempts	at Operation day (V2, up to 24 hours)
Secondary	Catheter placement (optimal vs. not optimal)	Optimal catheter Placement: free-floating within the Cerebrospinal fluid (CSF) without touching ventricle wall or septum pellucidum, and the tip of the catheter located at the foramen of Monro showing an optimal length of the catheter. Catheters that did not fulfill all criteria have been defined as not optimal placed. Positioning of catheters will be further graded according to Yim et al. into grades I to IV (grade I: catheter terminates in the ipsilateral frontal horn, grade II: catheter terminates in contralateral frontal horn, grade III: catheter terminates in non-targeted CSF spaces, grade IV: catheter terminates intraparenchymally)	at Operation day (V2,up to 24 hours), 2-3 days post-op. (V3), at discharge (V 4, approx. 7 days postop.), 6-8 weeks post-op (V5),6 months postop. (V6)
Secondary	Change in volumetry of side ventricles	Change in volumetry of side ventricles pre- and postoperatively in cm3 (number and relative change)	1 day before Operation day (V1, up to 24 hours) and 2-3 days post-op. (V3)
Secondary	Change in Evan's Index	Change in Evan's Index pre- and postoperatively (number and relative change).The Evans' index is the ratio of maximum width of the frontal horns of the lateral ventricles and the maximal internal diameter of the skull at the same level employed in axial CT images.	before Operation day (V1) and 2-3 days post-op. (V3)
Secondary	rate of complications (infection, bleeding, complications associated with navigation method)	rate of complications (infection, bleeding, complications associated with navigation method)	from Operation day (V2, up to 24 hours) until 6 months postop. (V6)
Secondary	mortality	mortality	from Operation day (V2, up to 24 hours) until 6 months postop. (V6)
Secondary	revision surgery (yes/no)	revision surgery (yes/no)	from Operation day (V2,up to 24 hours) until 6 months postop. (V6)